Comera Life Sciences Inc. (CMRAW) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Comera Life Sciences Inc...

    NASDAQ: CMRAW · Real-Time Price · USD
    0.02
    null (null%)
    At close: Sep 17, 2024, 10:00 PM

    Comera Life Sciences Cash Flow Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -18M -5.45M
    Depreciation & Amortization
    		 93.95K 86.14K
    Stock-Based Compensation
    		 375.79K 1.11M
    Other Working Capital
    		 1.72M -28.95K
    Other Non-Cash Items
    		 5.21M 79.42K
    Deferred Income Tax
    		 n/a -160.59K
    Change in Working Capital
    		 2.55M 574.2K
    Operating Cash Flow
    		 -9.77M -3.76M
    Capital Expenditures
    		 -28.61K -142.01K
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a
    Other Investing Acitivies
    		 n/a n/a
    Investing Cash Flow
    		 -28.61K -142.01K
    Debt Repayment
    		 n/a 750K
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 4.41M 180K
    Financial Cash Flow
    		 5.24M 10.28M
    Net Cash Flow
    		 -4.56M 6.38M
    Free Cash Flow
    		 -9.8M -3.9M

    Add to Watchlist